观察替格瑞洛在冠心病患者中的临床疗效

Clinical Efftof Ticagrelor in Patients with Coronary Heart Disease

目的观察替格瑞洛在冠心病患者中的临床疗效。方法选取2017年3月至2018年10月苏州市吴江区第四人民医院收治的冠心病患者64例为研究对象,采取随机表法将所有患者分为对照组(32例)与观察组(32例)。对照组采用氢氯吡格雷进行治疗,而观察组采用替格瑞洛进行治疗,比较两组患者的临床疗效以及不良反应发生率。结果治疗后,观察组的总有效率(96.88%)明显高于对照组(75.00%,P<0.05),且观察组的不良反应发生率(9.38%)与对照组(12.50%)相似,组间比较差异无统计学意义(P>0.05)。结论在冠心病的治疗中采用替格瑞洛具有显著的临床疗效,且不会增加不良反应,安全性高。

Objective To observe the clinical effect of ticagrelor in patients with coronary heart disease.Methods A total of 64 patients with coronary heart disease admitted to the fourth people's Hospital of Wujiang District,Suzhou City from March 2017 to October 2018 were enrolled.All patients were randomly divided into control group(32 cases)and observation group(32 cases).The control group was treated with hydroclopidogrel,while the observation group was treated with teglerol The clinical efficacy and incidence of adverse reactions were compared between the two groups.Results After treatment,the total effective rate of the observation group(96.88%)was significantly higher than that of the control group(75.00%,P<0.05),and the incidence of adverse reactions in the observation group(9.38%)was comparable to that of the control group(12.50%).The difference was not statistically significant(P>0.05).Conclusion The use of ticagrelor in the treatment of coronary heart disease has significant clinical efficacy without increasing adverse reactions and high safety.